Vibramycin and Compazine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Vibramycin (doxycycline) and Compazine (prochlorperazine maleate). Common drug interactions include drug hypersensitivity among females and bacteraemia among males.

The phase IV clinical study analyzes what interactions people have when they take Vibramycin and Compazine. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Vibramycin?

Vibramycin has active ingredients of doxycycline. It is often used in acne. eHealthMe is studying from 1,692 Vibramycin users. Check the latest studies of Vibramycin.

What is Compazine?

Compazine has active ingredients of prochlorperazine maleate. It is often used in nausea and vomiting. eHealthMe is studying from 13,646 Compazine users. Check the latest studies of Compazine.



On Aug, 07, 2026

14 people who take Vibramycin and Compazine together, and have interactions are studied.

Vibramycin and Compazine drug interactions.

What are the common drug interactions of Vibramycin and Compazine, by gender? *:

female:

  1. Drug hypersensitivity
  2. Anaemia (lack of blood)
  3. Dehydration (dryness resulting from the removal of water)
  4. Diarrhoea
  5. Hyperglycaemia (high blood sugar)
  6. Hypocalcaemia (levels of calcium in blood serum are abnormally low)
  7. Lymphocyte count decreased
  8. Sinus tachycardia (a heart rhythm with elevated rate of impulses originating from the sinoatrial node)
  9. Urinary tract infection
  10. Abdominal pain lower

male:

  1. Bacteraemia (presence of bacteria in the blood)
  2. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  3. Renal cancer (cancer of kidney)
  4. Small intestinal obstruction (blockage in small intestine)
  5. Disease progression
  6. Drug eruption (adverse drug reaction of the skin)
  7. Hypotension (abnormally low blood pressure)
  8. Ischaemic cardiomyopathy (weakness in the muscle of the heart due to inadequate oxygen delivery to the myocardium with coronary artery disease)
  9. Lung adenocarcinoma stage iv (the cancer has spread to other organs of the body, such as the other lung, brain, or liver)
  10. Night sweats (sweating in night)

What are the common drug interactions of Vibramycin and Compazine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Atrial thrombosis (blood clot that develops in an artery)

30-39:

n/a

40-49:

  1. Drug hypersensitivity
  2. Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)

50-59:

  1. Anaemia (lack of blood)
  2. Dehydration (dryness resulting from the removal of water)
  3. Diarrhoea
  4. Hyperglycaemia (high blood sugar)
  5. Hypocalcaemia (levels of calcium in blood serum are abnormally low)
  6. Lymphocyte count decreased
  7. Sinus tachycardia (a heart rhythm with elevated rate of impulses originating from the sinoatrial node)
  8. Urinary tract infection
  9. Drug eruption (adverse drug reaction of the skin)

60+:

  1. Drug hypersensitivity
  2. Bacteraemia (presence of bacteria in the blood)
  3. Renal cancer (cancer of kidney)
  4. Small intestinal obstruction (blockage in small intestine)
  5. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  6. Disease progression
  7. Hypotension (abnormally low blood pressure)
  8. Ischaemic cardiomyopathy (weakness in the muscle of the heart due to inadequate oxygen delivery to the myocardium with coronary artery disease)
  9. Lung adenocarcinoma stage iv (the cancer has spread to other organs of the body, such as the other lung, brain, or liver)
  10. Night sweats (sweating in night)

What are the existing conditions these people have? *

  1. Nausea (feeling of having an urge to vomit): 3 people, 21.43%
  2. Pain: 3 people, 21.43%
  3. Lung Cancer - Non-Small Cell (lung cancer): 2 people, 14.29%
  4. Constipation: 2 people, 14.29%
  5. Dermatitis Acneiform (dermatoses including acne vulgaris, rosacea, folliculitis, and perioral dermatitis): 1 person, 7.14%
  6. Folliculitis (infection of hair root): 1 person, 7.14%
  7. Enlarged Prostate: 1 person, 7.14%
  8. Electrolyte Imbalance: 1 person, 7.14%
  9. Diarrhea: 1 person, 7.14%
  10. Diabetes: 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Vibramycin and Compazine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Vibramycin and Compazine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Vibramycin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Compazine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Vibramycin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Compazine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on doxycycline and prochlorperazine maleate (the active ingredients of Vibramycin and Compazine, respectively), and Vibramycin and Compazine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: